RA Capital Healthcare Fund LP Sells Over $10 Million in Vor Biopharma Shares
VOR has more than doubled off its 52-week low of $2.622.
Summary
RA Capital Healthcare Fund LP, a 10% owner and director, reported selling an additional $10.2 million worth of Vor Biopharma common stock in open market transactions between April 8 and April 10, 2026.
Key Events · Ownership and Investor Activity · VOR
-
Significant Insider Sale
RA Capital Healthcare Fund LP, a 10% owner and director, disposed of 620,133 shares of Vor Biopharma common stock for a total value of $10,233,811 across four transactions.
-
Continuation of Selling Trend
These sales occurred between April 8 and April 10, 2026, following a previous sale of over $14.5 million by the same entity reported on April 6, 2026, indicating a sustained reduction in holdings.
-
Post-Transaction Holdings
Following these transactions, RA Capital Healthcare Fund LP's indirect holdings in Vor Biopharma stand at 3,935,608 shares.
Analysis · VOR · Life Sciences
RA Capital Healthcare Fund LP, a significant institutional investor and board member, has continued to reduce its stake in Vor Biopharma. This sale of over $10 million in shares, following a previous disposition of $14.5 million reported just days prior, indicates a sustained reduction in exposure. While such sales by financial investors can be for portfolio rebalancing, the substantial value of these transactions, especially in the context of Vor Biopharma's recently reported $696.0 million net loss and negative equity for 2025, could signal a lack of conviction or a strategic shift away from the company. Investors should note the cumulative selling pressure from this key insider.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.3% of the 1324 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VOR was trading at $15.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $755.7M. The 52-week trading range was $2.62 to $65.80. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.